Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
7.98M
-
Shares change
-
-14.7M
-
Total reported value, excl. options
-
$14.3M
-
Value change
-
-$53.1M
-
Put/Call ratio
-
1.22
-
Number of buys
-
27
-
Number of sells
-
-31
-
Price
-
$1.79
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q1 2015
68 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q1 2015.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.98M shares
of 29.5M outstanding shares and own 27.01% of the company stock.
Largest 10 shareholders include FMR LLC (1.45M shares), FIRST MANHATTAN CO (1.05M shares), DEERFIELD MANAGEMENT CO (803K shares), VANGUARD GROUP INC (791K shares), PANAGORA ASSET MANAGEMENT INC (650K shares), BVF INC/IL (600K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (451K shares), SABBY MANAGEMENT, LLC (296K shares), GROUP ONE TRADING, L.P. (232K shares), and MILLENNIUM MANAGEMENT LLC (223K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.